Literature DB >> 21308556

Vulvovaginal Candidiasis Caused by Non-albicans Candida Species: New Insights.

Melissa A Kennedy1, Jack D Sobel.   

Abstract

Non-albicans Candida species have increasingly been identified as the cause of vulvovaginitis. In vitro and in vivo data indicate that the various non-albicans Candida species identified in the lower genital tract differ considerably with regard to epidemiology, virulence or vaginal pathogenicity, and antimycotic drug susceptibility. Clinical experience indicates reduced virulence of these organisms in the lower genital tract, and their causal role in a symptomatic patient requires careful case-by-case determination rather than routine administration of antimycotic therapy. Accordingly, vaginal Candida isolates deserve species identification and consideration of pathogenic potential and antifungal susceptibility before therapeutic decisions are made.

Entities:  

Year:  2010        PMID: 21308556     DOI: 10.1007/s11908-010-0137-9

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  15 in total

1.  Management of Infections Caused by Candida glabrata.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-10       Impact factor: 3.725

2.  Geographic variation in the frequency of isolation and fluconazole and voriconazole susceptibilities of Candida glabrata: an assessment from the ARTEMIS DISK Global Antifungal Surveillance Program.

Authors:  Michael A Pfaller; Daniel J Diekema; David L Gibbs; Vance A Newell; Richard Barton; Hu Bijie; Jacques Bille; Shan-Chwen Chang; Maria da Luz Martins; Adriano Duse; Danuta Dzierzanowska; David Ellis; Jorge Finquelievich; Ian Gould; Deniz Gur; Anwar Hoosen; Kyungwon Lee; Nada Mallatova; Michele Mallie; N G Kee Peng; George Petrikos; Axel Santiago; Jan Trupl; Ann Marie VanDen Abeele; Jeannette Wadula; Mussaret Zaidi
Journal:  Diagn Microbiol Infect Dis       Date:  2010-03-24       Impact factor: 2.803

3.  Prevalence of and risk factors for fungal vaginitis caused by non-albicans species.

Authors:  A Spinillo; E Capuzzo; R Gulminetti; P Marone; L Colonna; G Piazzi
Journal:  Am J Obstet Gynecol       Date:  1997-01       Impact factor: 8.661

4.  Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases.

Authors:  Sandra S Richter; Rudolph P Galask; Shawn A Messer; Richard J Hollis; Daniel J Diekema; Michael A Pfaller
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

5.  Prevalence & susceptibility to fluconazole of Candida species causing vulvovaginitis.

Authors:  Srujana Mohanty; Immaculata Xess; Fahmi Hasan; Arti Kapil; Suneeta Mittal; Jorge E Tolosa
Journal:  Indian J Med Res       Date:  2007-09       Impact factor: 2.375

6.  Treatment of vaginitis caused by Candida glabrata: use of topical boric acid and flucytosine.

Authors:  Jack D Sobel; Walter Chaim; Viji Nagappan; Deborah Leaman
Journal:  Am J Obstet Gynecol       Date:  2003-11       Impact factor: 8.661

7.  Prevalence of Candida species and potential risk factors for vulvovaginal candidiasis in Aligarh, India.

Authors:  Anis Ahmad; Asad U Khan
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2009-03-03       Impact factor: 2.435

Review 8.  Vulvovaginal candidosis.

Authors:  Jack D Sobel
Journal:  Lancet       Date:  2007-06-09       Impact factor: 79.321

9.  Clinical characteristics of vulvovaginal candidiasis and antifungal susceptibilities of Candida species isolates among patients in southern China from 2003 to 2006.

Authors:  Shang Rong Fan; Xiao Ping Liu; Jian Wu Li
Journal:  J Obstet Gynaecol Res       Date:  2008-08       Impact factor: 1.730

10.  Vaginopathic and proteolytic Candida species in outpatients attending a gynaecology clinic.

Authors:  L Agatensi; F Franchi; F Mondello; R L Bevilacqua; T Ceddia; F De Bernardis; A Cassone
Journal:  J Clin Pathol       Date:  1991-10       Impact factor: 3.411

View more
  23 in total

1.  Sexually transmitted diseases treatment guidelines, 2015.

Authors:  Kimberly A Workowski; Gail A Bolan
Journal:  MMWR Recomm Rep       Date:  2015-06-05

2.  Comparison of the therapeutic effects of Garcin(®) and fluconazole on Candida vaginitis.

Authors:  Farzaneh Ebrahimy; Mahrokh Dolatian; Fariborz Moatar; Hamid Alavi Majd
Journal:  Singapore Med J       Date:  2015-10       Impact factor: 1.858

3.  Mouse strain-dependent differences in estrogen sensitivity during vaginal candidiasis.

Authors:  Paolo Mosci; Donatella Pietrella; Giovanni Ricci; Neelam Pandey; Claudia Monari; Eva Pericolini; Elena Gabrielli; Stefano Perito; Francesco Bistoni; Anna Vecchiarelli
Journal:  Mycopathologia       Date:  2012-10-07       Impact factor: 2.574

4.  Clinical Validation of a Test for the Diagnosis of Vaginitis.

Authors:  Charlotte A Gaydos; Sajo Beqaj; Jane R Schwebke; Joel Lebed; Bonnie Smith; Thomas E Davis; Kenneth H Fife; Paul Nyirjesy; Timothy Spurrell; Dorothy Furgerson; Jenell Coleman; Sonia Paradis; Charles K Cooper
Journal:  Obstet Gynecol       Date:  2017-07       Impact factor: 7.661

5.  Antifungal Activity of the Noncytotoxic Human Peptide Hepcidin 20 against Fluconazole-Resistant Candida glabrata in Human Vaginal Fluid.

Authors:  Gaetano Del Gaudio; Lisa Lombardi; Giuseppantonio Maisetta; Semih Esin; Giovanna Batoni; Maurizio Sanguinetti; Sonia Senesi; Arianna Tavanti
Journal:  Antimicrob Agents Chemother       Date:  2013-06-24       Impact factor: 5.191

6.  Comparative Analysis of the Capacity of the Candida Species To Elicit Vaginal Immunopathology.

Authors:  Hubertine M E Willems; David J Lowes; Katherine S Barker; Glen E Palmer; Brian M Peters
Journal:  Infect Immun       Date:  2018-11-20       Impact factor: 3.441

7.  Vulvovaginal candidiasis and current perspectives: new risk factors and laboratory diagnosis by using MALDI TOF for identifying species in primary infection and recurrence.

Authors:  Lívia Custódio Pereira; Amabel Fernandes Correia; Zita Dinis Lopes da Silva; Ceres Nunes de Resende; Fabiana Brandão; Rosane Mansan Almeida; Yanna Karla de Medeiros Nóbrega
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-03-13       Impact factor: 3.267

8.  Hosting infection: experimental models to assay Candida virulence.

Authors:  Donna M Maccallum
Journal:  Int J Microbiol       Date:  2011-12-22

Review 9.  It Takes Two to Tango: How a Dysregulation of the Innate Immunity, Coupled With Candida Virulence, Triggers VVC Onset.

Authors:  Andrea Ardizzoni; Robert T Wheeler; Eva Pericolini
Journal:  Front Microbiol       Date:  2021-06-07       Impact factor: 6.064

10.  Characterization of the vaginal micro- and mycobiome in asymptomatic reproductive-age Estonian women.

Authors:  Tiina Drell; Triin Lillsaar; Lea Tummeleht; Jaak Simm; Anu Aaspõllu; Edda Väin; Ivo Saarma; Andres Salumets; Gilbert G G Donders; Madis Metsis
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.